Heme oxygenase-1 attenuates epithelial-to-mesenchymal transition of human peritoneal mesothelial cells

Clinical and Experimental Nephrology

Volumn 17, Issue 2, 2013, Pages 284-293

  Bang, Kitae ^a   Jeong, Jinuk ^a   Shin, Jong Ho ^a   Kang, Ju Hyung ^a   Kim, Chang Nam ^a   Yeom, Hye Jung ^b   Yoon, Myeong Ok ^b   Yang, Jaeseok ^b,c   Ahn, Curie ^b,c   Hwang, Jong Ik ^d   Park, Mee Young ^a   Kim, Joo Heon ^a   Lee, Kang Wook ^e  

^a Eulji University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Chungnam National University   (South Korea)

Author keywords

Epithelial to mesenchymal transition; Heme oxygenase 1; Peritoneal fibrosis

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; HEME OXYGENASE 1; HEMIN; UVOMORULIN; ACTA2 PROTEIN, HUMAN; ACTIN; CADHERIN; GLUCOSE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OMENTUM; PERITONEAL FIBROSIS; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADENO ASSOCIATED VIRUS; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; EPITHELIUM CELL; FIBROSIS; GENE TRANSFER; GENE VECTOR; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PERITONEUM; PHYSIOLOGY; PLASMID; POLYMERASE CHAIN REACTION; DEPENDOPARVOVIRUS; DRUG EFFECTS;

ACTINS; CADHERINS; DEPENDOVIRUS; ENZYME INDUCTION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUCOSE; HEME OXYGENASE-1; HEMIN; HUMANS; IMMUNOHISTOCHEMISTRY; PERITONEUM; PLASMIDS; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84891426207     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0699-y     Document Type: Article

References (38)

1. Davies SJ, Phillips L, Griffiths AM, Russell LH. Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54(6):2207-17.
2. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int. 1999;55(l):341-56.
3. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12(5):1046-51.
4. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470-9.
5. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG. et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999; 19(6):517-25.
6. Plum J, Hermann S, Fussholler A, Schoenicke G, Donner A, Rohrborn A, et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl. 2001;78:S42-7.
7. Cendoroglo M, Sundaram S, Jaber BL, Pereira BJ. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis. 1998;31(2):273-82.
8. Gotloib L, Waisbrut V, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions. Nephron. 1995;70(4):466-77.
9. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to- mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348(5):403-13.
10. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;35(4):644-52.
11. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23(6):530-41.
12. Strippoli R, Benedicto I, Perez Lozano ML, Cerezo A, Lopez-Cabrera M, del Pozo MA. Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snaill pathway. Dis Model Mech. 2008;1(4-5):264-74.
13. Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Bio-chem. 1988;20(6):543-58.
14. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2(10):2557-68.
15. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996;15(1):9-19.
16. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-54.
17. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest. 1992;90(l):267-70.
18. Ishida Y, Nakamoto H, Imai H, Suzuki S, Okano H, Suzuki H. Heme oxygenase-1 regulates vascular tone of the peritoneum undergoing peritoneal dialysis. Adv Perit Dial. 2001;17:15-9.
19. Kim JH, Yang JI, Jung MH, Hwa JS, Kang KR, Park DJ, et al. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J Am Soc Nephrol. 2006;17(5): 1373-81.
20. Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N. Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol. 2008;19(9):1681-91.
21. Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit Dial Int. 1999;19(3):221-30.
22. Yung S, Li FK, Chan TM. Peritoneal mesothelial cell culture and biology. Perit Dial Int. 2006;26(2):162-73.
23. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95(5):2509-14.
24. Hwang JI, Oh YS, Shin KJ, Kim H, Ryu SH, Suh PG. Molecular cloning and characterization of a novel phospholipase C, PLCeta. Biochem J. 2005;389(Pt 1):181-6.
25. Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, Park SH, et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-tomesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol. 2009;20(3):567-81.
26. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis. 2005;46(5):938-48.
27. Aroeira LS, Lara-Pezzi E, Loureiro J, Aguilera A, Ramirez-Huesca M, Gonzalez-Mateo G, et al. Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. J Am Soc Nephrol. 2009;20(3):582-92.
28. Del Peso G, Jimenez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, Fernandez-Perpen A, et al. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl. 2008;108:S26-33.
29. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18(7):2004-13.
30. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112(12):1776-84.
31. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004;15(1):1-12.
32. Loureiro J, Schilte M, Aguilera A, Albar-Vizcaino P, Ramirez-Huesca M, Perez-Lozano ML, et al. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant. 2010;25(4):1098-108.
33. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. CurrOpin NephrolHypertens. 2003;12(1):25-9.
34. Nakamura S, Niwa T. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol. 2005;16(1):144-50.
35. Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol. 2005;16(1):68-78.
36. Kim HP, Pae HO, Back SH, Chung SW, Woo JM, Son Y, et al. Heme oxygenase-1 comes back to endoplasmic reticulum. Biochem Biophys Res Commun. 2011;404(1):1-5.
37. Liu XM, Peyton KJ, Ensenat D, Wang H, Schafer AI, Alam J, et al. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle. Role in cell survival. J Biol Chem. 2005;280(2):872-7.
38. Kim KM, Pae HO, Zheng M, Park R, Kim YM, Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res. 2007;101(9):919-27.